These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


89 related items for PubMed ID: 3287298

  • 1. [Proteins C and S of coagulation: new markers of thrombotic risk in nephrotic syndromes?].
    Rostoker G, Pech MA, Lagrue G.
    Pathol Biol (Paris); 1988 Apr; 36(4):297-9. PubMed ID: 3287298
    [Abstract] [Full Text] [Related]

  • 2. [Study of the protein C-protein S system in glomerulopathies and nephrotic syndrome].
    Rostoker G, Gouault-Heilmann M, Levent M, Lang P, Robeva R, Lagrue G.
    Nouv Rev Fr Hematol (1978); 1986 Apr; 28(6):359-63. PubMed ID: 2951650
    [Abstract] [Full Text] [Related]

  • 3. [Anomalies of coagulation and thromboembolic complications of nephrotic syndromes].
    Rostoker G, Gouault-Heilmann M, Lang P, Lagrue G.
    Pathol Biol (Paris); 1987 Feb; 35(2):195-9. PubMed ID: 3550633
    [Abstract] [Full Text] [Related]

  • 4. Protein C and protein S in pediatric nephrotic patients.
    Yermiahu T, Shalev H, Landau D, Dvilansky A.
    Sangre (Barc); 1996 Apr; 41(2):155-7. PubMed ID: 9045358
    [Abstract] [Full Text] [Related]

  • 5. [Thrombotic complications in the nephrotic syndrome].
    Keusch G.
    Schweiz Med Wochenschr; 1989 Aug 08; 119(31-32):1080-5. PubMed ID: 2678444
    [Abstract] [Full Text] [Related]

  • 6. [Complications of nephrotic syndrome with special reference to thromboembolic accidents].
    Kuhlmann U, Blättler W, Pouliadis G, Siegenthaler W.
    Schweiz Med Wochenschr; 1979 Feb 10; 109(6):200-9. PubMed ID: 370977
    [Abstract] [Full Text] [Related]

  • 7. Thromboembolic risks and complications in nephrotic children.
    Schlegel N.
    Semin Thromb Hemost; 1997 Feb 10; 23(3):271-80. PubMed ID: 9255908
    [Abstract] [Full Text] [Related]

  • 8. Adult patients with the nephrotic syndrome: really at high risk for deep venous thromboembolism? Report of a series and review of the literature.
    Ruggeri M, Milan M, La Greca G, Castaman G, Rodeghiero F.
    Haematologica; 1993 Feb 10; 78(6 Suppl 2):47-51. PubMed ID: 8039758
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the hypercoagulable state by measuring protein C and antithrombin III levels in nephrotic syndrome and in familial Mediterranean fever-related amyloidosis.
    Topaloğlu R, Saatçi U, Bakkaloğlu A, Beşbaş N, Başsoy Y.
    Turk J Pediatr; 1992 Feb 10; 34(1):15-20. PubMed ID: 1509525
    [Abstract] [Full Text] [Related]

  • 10. [Thrombosis and disorders of hemostasis in nephrotic syndrome].
    Kanfer A.
    Nephrologie; 1992 Feb 10; 13(4):151-7. PubMed ID: 1407255
    [Abstract] [Full Text] [Related]

  • 11. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C.
    Clin Endocrinol (Oxf); 2006 Mar 10; 64(3):323-9. PubMed ID: 16487444
    [Abstract] [Full Text] [Related]

  • 12. High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria.
    Ariëns RA, Moia M, Rivolta E, Ponticelli C, Mannucci PM.
    Thromb Haemost; 1999 Sep 10; 82(3):1020-3. PubMed ID: 10494757
    [Abstract] [Full Text] [Related]

  • 13. High plasma levels of protein C activity and antigen in the nephrotic syndrome.
    Mannucci PM, Valsecchi C, Bottasso B, D'Angelo A, Casati S, Ponticelli C.
    Thromb Haemost; 1986 Feb 28; 55(1):31-3. PubMed ID: 3754658
    [Abstract] [Full Text] [Related]

  • 14. Acquired free protein S deficiency in children with steroid resistant nephrosis.
    Hanevold CD, Lazarchick J, Constantin MA, Hiott KL, Orak JK.
    Ann Clin Lab Sci; 1996 Feb 28; 26(3):279-82. PubMed ID: 8726222
    [Abstract] [Full Text] [Related]

  • 15. Lupus anticoagulant and thromboembolism: evaluation of fibrinogen, natural inhibitors and molecular markers of thrombosis.
    Gschwandtner ME, Eichinger S, Hütter D, Korninger L, Lechner K, Panzer S, Pabinger I.
    Blood Coagul Fibrinolysis; 1996 Apr 28; 7(3):325-30. PubMed ID: 8735139
    [Abstract] [Full Text] [Related]

  • 16. [Evaluation of selected parameters of hemostasis in patients with nephrotic syndrome].
    Rowiński M, Rydzewski A, Małyszko JS, Małyszko J, Myśliwiec M.
    Przegl Lek; 1994 Apr 28; 51(2):77-81. PubMed ID: 8058973
    [Abstract] [Full Text] [Related]

  • 17. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study.
    Mahmoodi BK, ten Kate MK, Waanders F, Veeger NJ, Brouwer JL, Vogt L, Navis G, van der Meer J.
    Circulation; 2008 Jan 15; 117(2):224-30. PubMed ID: 18158362
    [Abstract] [Full Text] [Related]

  • 18. Hemostatic profile in nephrotic syndrome.
    Anand NK, Chand G, Talib VH, Chellani H, Pande J.
    Indian Pediatr; 1996 Dec 15; 33(12):1005-12. PubMed ID: 9141800
    [Abstract] [Full Text] [Related]

  • 19. Thromboembolic complications in the nephrotic syndrome: pathophysiology and clinical management.
    Singhal R, Brimble KS.
    Thromb Res; 2006 Dec 15; 118(3):397-407. PubMed ID: 15990160
    [Abstract] [Full Text] [Related]

  • 20. Protein C.
    Esmon CT.
    Prog Hemost Thromb; 1984 Dec 15; 7():25-54. PubMed ID: 6099583
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 5.